G537-0169 Screening compound: 4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid

G537-0169 Screening compound: 4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid
G537-0169 Screening compound: 4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound G537-0169
4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G537-0169

Molecular Formula

C25H33ClN4O4 (C25 H33 ClN4 O4)

Compound Name

4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid

IUPAC name

4-[(Z)-({4-[2-(4-chlorophenoxy)ethyl]piperazin-1-yl}[(3-ethoxypropyl)amino]methylidene)amino]benzoic acid

SMILES

CCOCCCN/C(/N1CCN(CCOc(cc2)ccc2Cl)CC1)=N/c(cc1)ccc1C(O)=O

InChI

InChI=1S/C25H33ClN4O4/c1-2-33-18-3-12-27-25(28-22-8-4-20(5-9-22)24(31)32)30-15-13-29(14-16-30)17-19-34-23-10-6-21(26)7-11-23/h4-11H,2-3,12-19H2,1H3,(H,27,28)(H,31,32)

InChI Key

PSXUQYCHRLLLDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15017143

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

489.01

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.238

Distribution Coefficient, logD

4.238

Water Solubility, LogSw

-4.25

Polar Surface Area

68.722

Acid Dissociation Constant (pKa)

4.01

Base Dissociation Constant (pKb)

8.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

G537-0169 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Nervous system
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Nuclear receptors
  • Proteases

References: we are preparing a list of scientific research reports with G537-0169 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G537-0169?
Check Price and Availability of G537-0169, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G537-0169 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G537-0169
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G537-0169
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G537-0169 available by request